Literature DB >> 9161535

[Experimental radiosurgery in rats using gamma a "gamma knife". Description of a stereotactic device for small laboratory animals].

M Rey1, P A Valliccioni, M Vial, D Porcheron, J Regis, L Kerlerian-le Goff, A Nieoullon, Y Millet, J C Peragut.   

Abstract

To allow the experimental use in rats of a Gamma Knife Radiosurgical Unit, a stereotactic device adapted from the conventional Kopf's device was developed. To control the accuracy of the coordinate system based on the De Groot's rat stereotactic atlas, experimental radiosurgical lesions were made on the left striatum. The isodose curve distribution of the 4 mm collimator was calculated with the dose planning software used in Gamma Knife and superimposed on the left striatum target. Doses of 200 Gy were administered to the left striatum in six rats. The results were evaluated 21, 34 and 47 days later. At 34 and 47 days necrotic lesions were exactly as targeted. In a second group of 48 rats receiving a doses of 100 Gy, no lesions were observed after 7, 15, 24, 31, 45 days. However, in all rats sacrificed 59, 72 and 90 days after day radiation, a necrotic lesion was always present and confirmed that at each time the lesions were precisely targeted. This apparatus allows precise and reproducible gamma irradiation lesion in rat brain without expensive and time consuming imaging techniques. This device provides a useful system to observe the experimental effects of radiosurgery on the central nervous system in rats.

Entities:  

Mesh:

Year:  1996        PMID: 9161535

Source DB:  PubMed          Journal:  Neurochirurgie        ISSN: 0028-3770            Impact factor:   1.553


  2 in total

1.  Drug repurposing: sulfasalazine sensitizes gliomas to gamma knife radiosurgery by blocking cystine uptake through system Xc-, leading to glutathione depletion.

Authors:  L Sleire; B S Skeie; I A Netland; H E Førde; E Dodoo; F Selheim; L Leiss; J I Heggdal; P-H Pedersen; J Wang; P Ø Enger
Journal:  Oncogene       Date:  2015-03-23       Impact factor: 9.867

2.  Gamma knife surgery as monotherapy with clinically relevant doses prolongs survival in a human GBM xenograft model.

Authors:  Bente Sandvei Skeie; Jian Wang; Ernest Dodoo; Jan Ingeman Heggdal; Janne Grønli; Linda Sleire; Sidsel Bragstad; Jeremy C Ganz; Martha Chekenya; Sverre Mørk; Paal-Henning Pedersen; Per Øyvind Enger
Journal:  Biomed Res Int       Date:  2013-11-10       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.